News Releases

Norbrook® Launches Midamox™ for Dogs and Cats (imidacloprid + moxidectin), Providing Veterinarians and Pet Owners Effective, Affordable and Flexible Topical Parasite Control

by Animal Health2 | May 16, 2022

LENEXA, KS (April 2022) – Norbrook Inc., dedicated to providing quality veterinary  pharmaceuticals at an affordable price, today announced it has released Midamox™ topical  solution for both dogs and cats. Midamox™ is bioequivalent to the pioneer product, Advantage  Multi® for Dogs and Cats, but is much more affordable, allowing veterinarians to pass some of  that savings on to their clients, while also growing their clinic profits. 

“Parasite control and prevention is imperative to the safety of both pets and pet families.  Having access to affordable parasite control options for both the clinic and the pet owner  increases accessibility, helps to drive compliance and promotes the recommended year-round  prevention.” says Dr. Scott Krick, Technical Service Veterinarian, Norbrook. “At Norbrook, we  want to make it less burdensome for pet owners to protect their pets. Now, with several  parasite control options for both dogs and cats, pets can get the effective and flexible  treatment they need, clients get an affordable option, and clinics get a boost to their bottom  line.” 

Indications 

Midamox for Dogs is indicated for the prevention of heartworm disease caused by Dirofilaria  immitis and the treatment of Dirofilaria immitis circulating microfilariae in heartworm-positive  dogs. Midamox for Dogs kills adult fleas and is indicated for the treatment of flea infestations  (Ctenocephalides felis). Midamox for Dogs is indicated for the treatment and control of  sarcoptic mange caused by Sarcoptes scabiei var. canis. Midamox for Dogs is also indicated for  the treatment and control of the following intestinal parasites species: Hookworms (Ancyclostoma canium) (Uncinaria stenocephala), Roundworms (Toxocara canis) (Toxascaris  leonina) and Whipworms (Trichuris vulpis). 

Midamox for Cats is indicated for the prevention of heartworm disease caused by Dirofilaria  Immitis. Midamox for Cats kills adult fleas (Ctenocephalides felis) and is indicated for the  treatment of flea infestations. Midamox for Cats is indicated for the treatment and control of ear mite (Otodectes cynotis) infestations and the intestinal parasites species Hookworms  (Ancyclostoma tubaeforme) and Roundworm (Toxocara cati).

Dosing Made Easy 

Midamox™ is conveniently packaged in single dose applicators for monthly use. The product is  easily applied to the skin on the back of the neck after parting the pet’s coat, making  prevention a simple process. 

Affordability 

While efficacy is equivalent to Advantage Multi®, Midamox™ is more affordable. Veterinarians  can save 24% percent when choosing Midamox™ over the pioneer product, allowing them to  pass some of the savings on to clients while increasing practice profitability. 

About Norbrook 

Established in 1969, Norbrook is one of world’s largest manufacturers of veterinary sterile  injectables as well as companion animal and livestock private-label brands in the U.S. Norbrook  manufacturers many of its own active pharmaceutical ingredients (APIs), ensuring quality and  control over costs. With over 50 years of experience delivering trusted, quality brands for its  customers, it continues to drive the business forward by reinvesting in its infrastructure and  new product development. For more information about Norbrook brands, visit  www.norbrook.com. 

 

Search

Archive

Tweet @AHCorridor

Media Coverage

The Connector

KC Animal Health Blog

Benefits